SPONSOR
CellSight Technologies, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 2
CellSight Technologies, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Advanced Non Small Cell Lung Cancer, Non-small Cell Lung Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — CellSight Technologies, Inc.
How many clinical trials has CellSight Technologies, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by CellSight Technologies, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Advanced Non Small Cell Lung Cancer, Non-small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does CellSight Technologies, Inc. research focus on?
CellSight Technologies, Inc. clinical trials span Advanced Non Small Cell Lung Cancer, Non-small Cell Lung Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a CellSight Technologies, Inc. clinical trial?
To participate in a CellSight Technologies, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all CellSight Technologies, Inc. trials with current recruitment status updated daily.
Clinical Trials by CellSight Technologies, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology